Biopharmaceutical Company Issues Major Patents For For Alzheimer's Disease Treatment
ANEW MEDICAL, INC.: Pioneering Genetic Therapy for Neurodegenerative Diseases.
ANEW MEDICAL, INC. (NASDAQ: WENA), a biotechnology company based in the United States, has announced significant advancements in its mission to develop genetic therapies aimed at combating neurodegenerative diseases. Recently, the company was granted patents in major Asian markets, specifically Hong Kong and China, for its groundbreaking genetic approaches targeting diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). $Anew Medical (WENA.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment